top of page
Search

Presentation of our work at ESGCT 2026

ART-TG
2 days ago
1 min read

Our lab was presenting our work at the annual meeting of the European Society of Cell and Gene Therapy in Hamburg. We presented the development of a production process for the TREM2 lentiviral vector (Chabon et al. P0879) and the preclinical biosafety and biodistribution study for a bi-functional vector for the gene therapy of sickle cell disease (Tran et al. P0713)


 
 
 

Comments


ART-TG
Inserm US35
30 rue H. Desbruères
91100 Corbeil-Essonnes
France

Director :
Anne Galy PhD

Copyright @ ART-TG 2021

bottom of page